Drug Sponsors

ICREL Survey Findings Reveal Need for EU CT Directive Changes

Thursday, July 2, 2009

Multinational trials have become increasingly complex and timelines have lengthened since the European Union Clinical Trial Directive 2001/20/EC went into effect. This has resulted in stakeholders’ need for more staff and ultimately higher costs to run drug development programs in Europe. While stakeholders have anecdotally drawn similar conclusions, a report by The Impact on Clinical Research of European Legislation (ICREL), is now able to provide hard data to back up these claims. The report demonstrates the significant impact of the directive on all stakeholders.

[Read More]

AAHRPP Accredits Another 13

Thursday, June 18, 2009

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited another 13 organizations last week, bringing the total number of AAHRPP-accredited organizations to 188.

[Read More]